Select employers will have until January 1, 2016, to comply with a health insurance mandate under the Affordable Care Act(ACA). Originally, employers with 50 to 99 workers would have faced a penalty if they did not offer health insurance to their employees in 2014.
Select employers will have until January 1, 2016, to comply with a health insurance mandate under the Affordable Care Act(ACA). Originally, employers with 50 to 99 workers would have faced a penalty if they did not offer health insurance to their employees in 2014. This is the second 1-year extension for these employers. Companies with 100 or more employees have also received a 1 year extension, until January 1, 2015. In 2015, they will only have to offer insurance to at least 70% of their employees as opposed to the 95% that the law initially required. The tax penalties within the law are intended to offset the costs of the federal subsidies that are given to low-income individuals.
“Today’s final regulations phase in the standards to ensure that larger employers either offer quality affordable coverage or make an employer responsibility payment starting in 2015,” said Mark J. Mazur, the assistant Treasury secretary for tax policy.
The news has some worried, especially following the rollout troubles of the Heathcare.gov website. The delay is only 1 of many that have been put into place since the ACA was signed into law in 2010.
“The White House seems to have a new exemption from its failed law for a different group each month,” said Senator Mitch McConnell of Kentucky. “It’s time to extend that exemption to families and individuals—not just businesses.”
House Speaker John Boehner echoed McConnell’s comments saying, “If the administration doesn’t believe employers can manage the burden of the law, how can struggling families be expected to?”
The administration is still determining how to quantify certain workers’ eligibility for coverage, including part-time and seasonal workers. Overall, only 2% of employers have 51 to 100 employees, while 2% have more than 100 employees. Companies with more than 100 employees employ 66% of U.S. workers; those with 51 to 100 employ 7% of workers.
Around the Web
White House Delays Health Insurance Mandate for Medium-Sized Employers Until 2016
Further Delays for Employers in Health Law [The NY Times]
US to Further Delay Obamacare Employer Mandate [The Los Angeles Times]
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More